Entecavir
- Product NDC
- 63126-102
- 11-digit product format
- 631260102
- Labeler code
- 63126
- Product ID
- 63126-102_296df15a-92f7-4bec-916b-441fc1c71b3c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Entecavir
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- YUNG SHIN PHARM. IND. CO., LTD.
- Application
- ANDA208195
- Marketing category
- ANDA
- Marketing start
- 2022-04-30
- Marketing end
- 0000-00-00
- Substance
- ENTECAVIR
- Active strength
- 1 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63126-102-30 | 63126010230 | 30 TABLET, FILM COATED in 1 BOTTLE (63126-102-30) | 2022-04-30 | 0000-00-00 | No | No | Current |